MedPath

CO2-laser Treatment for Caesarean Section Scars

Not Applicable
Completed
Conditions
Cicatrix
Registration Number
NCT02651298
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Fractional Co2-laser for treatment of mature caesarean section scars.

Detailed Description

Randomized split scar study to document improvement of caesarean section scars as compared to untreated control scar.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
12
Inclusion Criteria
  • mature caesarean section scar
Exclusion Criteria
  • systemic uncontrolled disease
  • recent or current cancer
  • smoking
  • keloid formation
  • wounds or local disease int treatment area
  • pregnancy or lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
patient observer scar scaleup until 6 months post treatment

validated scar scale evaluations

Secondary Outcome Measures
NameTimeMethod
histology of scar tissue3 months post treatment
erythema measured by reflectance6 months post treatment

measured by reflectance

pigmentation measured by reflectance6 months post treatment

measured by reflectance

Trial Locations

Locations (1)

Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

Bispebjerg Hospital
🇩🇰Copenhagen, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.